Novo Nordisk A/S (NVO) Investment Research Dashboard
About Novo Nordisk A/S (NVO) stock analysis
Get live NVO stock price $50.96, comprehensive Novo Nordisk A/S stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time NVO stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Af...
Company Information
- CEO
- Maziar Mike Doustdar
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 77406
Contact Information
- Website
- https://www.novonordisk.com
- Address
- Novo Alle 1
- Country
- DK
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 226.5 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 12.7)
✓ Lower volatility stock (Beta: 0.36) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Novo Nordisk A/S shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Novo Nordisk A/S
- ⚠Investors should consider how Novo Nordisk A/S fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
226.46B
P/E Ratio (TTM)
12.65
Beta
0.36
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NVO with peer companies:
- Price
- $107.32+2.71% (1D)
- Market cap
- 186.93B
- Price
- $393.10+4.48% (1D)
- Market cap
- 212.16B
- Price
- $172.48+1.67% (1D)
- Market cap
- 133.67B
- Price
- $134.32+2.91% (1D)
- Market cap
- 166.77B
- Price
- $53.71+3.33% (1D)
- Market cap
- 108.36B
- Price
- $131.84+0.82% (1D)
- Market cap
- 325.61B
- Price
- $159.85+2.40% (1D)
- Market cap
- 303.83B
- Price
- $25.25+2.35% (1D)
- Market cap
- 143.91B
- Price
- $45.54+3.50% (1D)
- Market cap
- 110.48B
- Price
- $576.41+3.02% (1D)
- Market cap
- 214.21B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.8 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.4% | 29.2 | 46/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.